- ProBioGen has launched a redesigned website to provide biotech and biopharma professionals with easier access to its CDMO services and proprietary technologies.
- The platform features improved navigation, comprehensive service insights, and an enhanced user experience across all devices.
ProBioGen has unveiled a new, redesigned website aimed at improving accessibility to its expanded CDMO services and proprietary technologies. The updated platform offers streamlined navigation and faster access to essential information for biotech and biopharma professionals.
The new website enables visitors to efficiently explore ProBioGen’s service portfolio, including cell line development, cell banking, process and analytical development, and GMP manufacturing. It also highlights the company’s proprietary technologies, such as GlymaxX and DirectedLuck, designed to enhance efficacy, productivity, and speed to clinic.
Key improvements include dedicated sections for contract manufacturing services, scientific insights, and industry updates. The platform features detailed descriptions, white papers, and scientific studies to support informed decision-making for clients. Additionally, a fully responsive design ensures seamless access across all devices.
“Our relaunched website reflects ProBioGen’s commitment to innovation and partnership, putting our customers first,” said Dr. Gabriele Schneider, Chief Business Officer at ProBioGen. “By focusing on clarity and ease of use, the platform empowers visitors to make faster decisions, plan projects more effectively, and drive innovation in next-generation therapies.”